1. Home
  2. RECT vs NRSN Comparison

RECT vs NRSN Comparison

Compare RECT & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rectitude Holdings Ltd

RECT

Rectitude Holdings Ltd

HOLD

Current Price

$1.24

Market Cap

17.7M

Sector

N/A

ML Signal

HOLD

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.50

Market Cap

16.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RECT
NRSN
Founded
1997
2017
Country
Singapore
Israel
Employees
111
16
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
16.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RECT
NRSN
Price
$1.24
$0.50
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
8.8K
185.6K
Earning Date
03-20-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$583.67
P/E Ratio
$12.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.96
$0.39
52 Week High
$4.98
$1.33

Technical Indicators

Market Signals
Indicator
RECT
NRSN
Relative Strength Index (RSI) 47.37 33.34
Support Level $1.06 N/A
Resistance Level $1.40 $0.74
Average True Range (ATR) 0.17 0.08
MACD 0.00 -0.01
Stochastic Oscillator 26.15 33.65

Price Performance

Historical Comparison
RECT
NRSN

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

Share on Social Networks: